Class I — Serious Health Hazard

Serious health hazard — there is a reasonable probability that use of or exposure to this product will cause serious adverse health consequences or death.

OraQuick Ebola Rapid Antigen Test Recalled by OraSure Technologies, Inc. Due to Failed stability testing at 8 months. This lot...

Date: July 20, 2016
Company: OraSure Technologies, Inc.
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact OraSure Technologies, Inc. directly.

Affected Products

OraQuick Ebola Rapid Antigen Test, Product Code 3001-2807; Intended for the qualitative detection of antigens for Ebola viruses.

Quantity: 3,075 units

Why Was This Recalled?

Failed stability testing at 8 months. This lot produced intermittent false negative results for the positive kit control with devices stored at 30C conditions.

Where Was This Sold?

Distributed to one customer only in US state of Georgia.

About OraSure Technologies, Inc.

OraSure Technologies, Inc. has 10 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report